Annual Net Income
$53.87 M
+$28.42 M+111.70%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual net profit is currently $53.87 million, with the most recent change of +$28.42 million (+111.70%) on 31 March 2024. During the last 3 years, it has risen by +$440.52 million (+113.93%).TARO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$15.08 M
-$5.13 M-25.39%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly net profit is currently $15.08 million, with the most recent change of -$5.13 million (-25.39%) on 31 March 2024. Over the past year, it has increased by +$6.53 million (+76.41%).TARO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$53.87 M
+$8.16 M+17.87%
31 March 2024
Summary:
Taro Pharmaceutical Industries TTM net profit is currently $53.87 million, with the most recent change of +$8.16 million (+17.87%) on 31 March 2024. Over the past year, it has increased by +$21.11 million (+64.44%).TARO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +111.7% | +76.4% | +64.4% |
| 3 y3 years | +113.9% | -35.3% | +601.1% |
| 5 y5 years | -80.9% | -73.2% | -80.4% |
TARO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -90.0% | -92.0% | -90.7% |
Taro Pharmaceutical Industries Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $53.87 M(+111.7%) | $15.08 M(-25.4%) | $53.87 M(+17.9%) |
| Dec 2023 | - | $20.21 M(+136.4%) | $45.70 M(+39.5%) |
| Sept 2023 | - | $8.55 M(-14.8%) | $32.76 M(+53.1%) |
| June 2023 | - | $10.03 M(+45.1%) | $21.40 M(-15.9%) |
| Mar 2023 | $25.45 M(-56.3%) | $6.91 M(-4.8%) | $25.44 M(-44.6%) |
| Dec 2022 | - | $7.26 M(-358.3%) | $45.94 M(-29.3%) |
| Sept 2022 | - | -$2.81 M(-120.0%) | $64.98 M(-28.7%) |
| June 2022 | - | $14.08 M(-48.6%) | $91.11 M(+56.4%) |
| Mar 2022 | $58.27 M(-115.1%) | $27.40 M(+4.1%) | $58.27 M(+5310.1%) |
| Dec 2021 | - | $26.31 M(+12.8%) | $1.08 M(-86.0%) |
| Sept 2021 | - | $23.32 M(-224.2%) | $7.68 M(-74.0%) |
| June 2021 | - | -$18.77 M(-37.0%) | $29.50 M(-107.6%) |
| Mar 2021 | -$386.65 M(-258.3%) | -$29.79 M(-190.5%) | -$386.65 M(+27.7%) |
| Dec 2020 | - | $32.92 M(-27.1%) | -$302.67 M(+13.0%) |
| Sept 2020 | - | $45.13 M(-110.4%) | -$267.91 M(+4.3%) |
| June 2020 | - | -$434.92 M(-902.5%) | -$256.86 M(-205.2%) |
| Mar 2020 | $244.24 M(-13.3%) | $54.20 M(-19.9%) | $244.24 M(-1.7%) |
| Dec 2019 | - | $67.68 M(+20.5%) | $248.48 M(-9.4%) |
| Sept 2019 | - | $56.18 M(-15.1%) | $274.30 M(-2.3%) |
| June 2019 | - | $66.18 M(+13.3%) | $280.68 M(-0.4%) |
| Mar 2019 | $281.78 M(+33.4%) | $58.43 M(-37.5%) | $281.78 M(-9.0%) |
| Dec 2018 | - | $93.51 M(+49.5%) | $309.63 M(+32.3%) |
| Sept 2018 | - | $62.56 M(-7.0%) | $234.10 M(+4.5%) |
| June 2018 | - | $67.28 M(-22.0%) | $223.93 M(+6.1%) |
| Mar 2018 | $211.15 M(-53.7%) | $86.29 M(+380.1%) | $211.15 M(+1.6%) |
| Dec 2017 | - | $17.97 M(-65.7%) | $207.85 M(-37.0%) |
| Sept 2017 | - | $52.39 M(-3.9%) | $329.69 M(-17.8%) |
| June 2017 | - | $54.50 M(-34.3%) | $400.96 M(-12.1%) |
| Mar 2017 | $456.36 M(-15.6%) | $82.99 M(-40.6%) | $456.36 M(-6.5%) |
| Dec 2016 | - | $139.82 M(+13.1%) | $488.32 M(-9.1%) |
| Sept 2016 | - | $123.66 M(+12.5%) | $537.50 M(-1.8%) |
| June 2016 | - | $109.90 M(-4.4%) | $547.19 M(+1.2%) |
| Mar 2016 | $540.93 M(+11.7%) | $114.95 M(-39.2%) | $540.93 M(-6.5%) |
| Dec 2015 | - | $189.00 M(+41.7%) | $578.27 M(+8.7%) |
| Sept 2015 | - | $133.35 M(+28.7%) | $531.76 M(-1.9%) |
| June 2015 | - | $103.64 M(-31.9%) | $541.79 M(+11.9%) |
| Mar 2015 | $484.26 M(+34.4%) | $152.29 M(+6.9%) | $484.26 M(+14.9%) |
| Dec 2014 | - | $142.48 M(-0.6%) | $421.61 M(+6.8%) |
| Sept 2014 | - | $143.38 M(+211.0%) | $394.74 M(+13.5%) |
| June 2014 | - | $46.10 M(-48.6%) | $347.69 M(-3.5%) |
| Mar 2014 | $360.39 M(+35.4%) | $89.64 M(-22.5%) | $360.39 M(+12.7%) |
| Dec 2013 | - | $115.61 M(+20.0%) | $319.91 M(+9.2%) |
| Sept 2013 | - | $96.34 M(+63.8%) | $293.08 M(+11.8%) |
| June 2013 | - | $58.80 M(+19.6%) | $262.09 M(-1.5%) |
| Mar 2013 | $266.21 M(+463.4%) | $49.17 M(-44.6%) | $266.20 M(+0.7%) |
| Dec 2012 | - | $88.78 M(+35.8%) | $264.29 M(+11.1%) |
| Sept 2012 | - | $65.35 M(+3.9%) | $237.91 M(+2.8%) |
| June 2012 | - | $62.91 M(+33.1%) | $231.50 M(+13.3%) |
| Mar 2012 | $47.25 M(-74.1%) | $47.25 M(-24.3%) | $204.28 M(+11.8%) |
| Dec 2011 | $182.68 M(+185.1%) | $62.40 M(+5.9%) | $182.68 M(+33.6%) |
| Sept 2011 | - | $58.94 M(+65.1%) | $136.78 M(+41.9%) |
| June 2011 | - | $35.69 M(+39.1%) | $96.37 M(+24.9%) |
| Mar 2011 | - | $25.66 M(+55.6%) | $77.13 M(+28.5%) |
| Dec 2010 | $64.08 M(-43.8%) | $16.49 M(-11.0%) | $60.03 M(-51.7%) |
| Sept 2010 | - | $18.53 M(+12.7%) | $124.23 M(+7.6%) |
| June 2010 | - | $16.45 M(+92.4%) | $115.43 M(+3.6%) |
| Mar 2010 | - | $8.55 M(-89.4%) | $111.47 M(-2.2%) |
| Dec 2009 | $114.02 M(+273.6%) | $80.70 M(+729.8%) | $114.02 M(+271.1%) |
| Sept 2009 | - | $9.73 M(-22.1%) | $30.73 M(-8.4%) |
| June 2009 | - | $12.49 M(+12.5%) | $33.53 M(-1.6%) |
| Mar 2009 | - | $11.10 M(-527.9%) | $34.09 M(+48.3%) |
| Dec 2008 | $30.52 M(-11.1%) | -$2.60 M(-120.7%) | $22.98 M(-10.1%) |
| Sept 2008 | - | $12.53 M(-4.0%) | $25.58 M(+96.0%) |
| June 2008 | - | $13.05 M | $13.05 M |
| Dec 2007 | $34.34 M(-141.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | -$82.68 M(<-9900.0%) | - | - |
| Dec 2005 | $84.00 K(-99.2%) | -$12.48 M(-682.7%) | $1.18 M(-93.6%) |
| Sept 2005 | - | $2.14 M(-67.0%) | $18.45 M(-9.3%) |
| June 2005 | - | $6.49 M(+29.2%) | $20.34 M(+308.2%) |
| Mar 2005 | - | $5.03 M(+5.0%) | $4.98 M(-55.0%) |
| Dec 2004 | $11.07 M(-81.9%) | $4.79 M(+18.8%) | $11.07 M(-51.6%) |
| Sept 2004 | - | $4.03 M(-145.5%) | $22.90 M(-33.8%) |
| June 2004 | - | -$8.86 M(-179.7%) | $34.61 M(-40.6%) |
| Mar 2004 | - | $11.12 M(-33.1%) | $58.28 M(-4.7%) |
| Dec 2003 | $61.16 M(+37.3%) | $16.61 M(+5.6%) | $61.16 M(+6.4%) |
| Sept 2003 | - | $15.74 M(+6.2%) | $57.47 M(+7.8%) |
| June 2003 | - | $14.82 M(+5.9%) | $53.30 M(+9.5%) |
| Mar 2003 | - | $13.99 M(+8.2%) | $48.67 M(+9.2%) |
| Dec 2002 | $44.55 M(+71.4%) | $12.93 M(+11.8%) | $44.55 M(+7.5%) |
| Sept 2002 | - | $11.56 M(+13.5%) | $41.45 M(+11.3%) |
| June 2002 | - | $10.19 M(+3.2%) | $37.23 M(+12.5%) |
| Mar 2002 | - | $9.88 M(+0.5%) | $33.10 M(+25.5%) |
| Dec 2001 | $25.99 M(+159.2%) | $9.82 M(+33.9%) | $26.38 M(+31.4%) |
| Sept 2001 | - | $7.34 M(+21.1%) | $20.07 M(+29.1%) |
| June 2001 | - | $6.06 M(+91.9%) | $15.54 M(+34.5%) |
| Mar 2001 | - | $3.16 M(-10.1%) | $11.56 M(+15.3%) |
| Dec 2000 | $10.03 M(+81.0%) | $3.51 M(+25.0%) | $10.03 M(+21.5%) |
| Sept 2000 | - | $2.81 M(+35.5%) | $8.25 M(+15.6%) |
| June 2000 | - | $2.07 M(+27.4%) | $7.14 M(+12.2%) |
| Mar 2000 | - | $1.63 M(-6.4%) | $6.37 M(+14.9%) |
| Dec 1999 | $5.54 M(+140.8%) | $1.74 M(+2.3%) | $5.54 M(+10.8%) |
| Sept 1999 | - | $1.70 M(+30.8%) | $5.00 M(+25.0%) |
| June 1999 | - | $1.30 M(+62.5%) | $4.00 M(+33.3%) |
| Mar 1999 | - | $800.00 K(-33.3%) | $3.00 M(+30.4%) |
| Dec 1998 | $2.30 M(+64.3%) | $1.20 M(+71.4%) | $2.30 M(+76.9%) |
| Sept 1998 | - | $700.00 K(+133.3%) | $1.30 M(-7.1%) |
| June 1998 | - | $300.00 K(+200.0%) | $1.40 M(-6.7%) |
| Mar 1998 | - | $100.00 K(-50.0%) | $1.50 M(0.0%) |
| Dec 1997 | $1.40 M(-36.4%) | $200.00 K(-75.0%) | $1.50 M(-25.0%) |
| Sept 1997 | - | $800.00 K(+100.0%) | $2.00 M(+5.3%) |
| June 1997 | - | $400.00 K(+300.0%) | $1.90 M(-9.5%) |
| Mar 1997 | - | $100.00 K(-85.7%) | $2.10 M(-4.5%) |
| Dec 1996 | $2.20 M(+10.0%) | $700.00 K(0.0%) | $2.20 M(+37.5%) |
| Sept 1996 | - | $700.00 K(+16.7%) | $1.60 M(+77.8%) |
| June 1996 | - | $600.00 K(+200.0%) | $900.00 K(-40.0%) |
| Mar 1996 | - | $200.00 K(+100.0%) | $1.50 M(-25.0%) |
| Dec 1995 | $2.00 M(-41.2%) | $100.00 K(-91.7%) | $2.00 M(-45.9%) |
| June 1995 | - | $1.20 M(+71.4%) | $3.70 M(+5.7%) |
| Mar 1995 | - | $700.00 K(-36.4%) | $3.50 M(+6.1%) |
| Dec 1994 | $3.40 M(+1600.0%) | $1.10 M(+57.1%) | $3.30 M(+22.2%) |
| Sept 1994 | - | $700.00 K(-30.0%) | $2.70 M(+42.1%) |
| June 1994 | - | $1.00 M(+100.0%) | $1.90 M(+111.1%) |
| Mar 1994 | - | $500.00 K(0.0%) | $900.00 K(+350.0%) |
| Dec 1993 | $200.00 K(-77.8%) | $500.00 K(-600.0%) | $200.00 K(-122.2%) |
| Sept 1993 | - | -$100.00 K(-50.0%) | -$900.00 K(-550.0%) |
| Mar 1993 | - | -$200.00 K(-66.7%) | $200.00 K(-77.8%) |
| Dec 1992 | $900.00 K(+12.5%) | -$600.00 K(-200.0%) | $900.00 K(-40.0%) |
| Sept 1992 | - | $600.00 K(+50.0%) | $1.50 M(0.0%) |
| June 1992 | - | $400.00 K(-20.0%) | $1.50 M(+66.7%) |
| Mar 1992 | - | $500.00 K(>+9900.0%) | $900.00 K(0.0%) |
| Dec 1991 | $800.00 K(-500.0%) | $0.00(-100.0%) | $900.00 K(+12.5%) |
| Sept 1991 | - | $600.00 K(-400.0%) | $800.00 K(+300.0%) |
| June 1991 | - | -$200.00 K(-140.0%) | $200.00 K(-60.0%) |
| Mar 1991 | - | $500.00 K(-600.0%) | $500.00 K(-350.0%) |
| Dec 1990 | -$200.00 K(0.0%) | -$100.00 K(-200.0%) | -$200.00 K(-50.0%) |
| June 1990 | - | $100.00 K(-150.0%) | -$400.00 K(-20.0%) |
| Mar 1990 | - | -$200.00 K(-33.3%) | -$500.00 K(+150.0%) |
| Dec 1989 | -$200.00 K(-300.0%) | -$300.00 K(-400.0%) | -$200.00 K(-200.0%) |
| Mar 1989 | - | $100.00 K(>+9900.0%) | $200.00 K(+100.0%) |
| Dec 1988 | $100.00 K | $0.00(-100.0%) | $100.00 K(0.0%) |
| June 1988 | - | $100.00 K | $100.00 K |
FAQ
- What is Taro Pharmaceutical Industries annual net profit?
- What is the all time high annual net income for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual net income year-on-year change?
- What is Taro Pharmaceutical Industries quarterly net profit?
- What is the all time high quarterly net income for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly net income year-on-year change?
- What is Taro Pharmaceutical Industries TTM net profit?
- What is the all time high TTM net income for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries TTM net income year-on-year change?
What is Taro Pharmaceutical Industries annual net profit?
The current annual net income of TARO is $53.87 M
What is the all time high annual net income for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual net profit is $540.93 M
What is Taro Pharmaceutical Industries annual net income year-on-year change?
Over the past year, TARO annual net profit has changed by +$28.42 M (+111.70%)
What is Taro Pharmaceutical Industries quarterly net profit?
The current quarterly net income of TARO is $15.08 M
What is the all time high quarterly net income for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly net profit is $189.00 M
What is Taro Pharmaceutical Industries quarterly net income year-on-year change?
Over the past year, TARO quarterly net profit has changed by +$6.53 M (+76.41%)
What is Taro Pharmaceutical Industries TTM net profit?
The current TTM net income of TARO is $53.87 M
What is the all time high TTM net income for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high TTM net profit is $578.27 M
What is Taro Pharmaceutical Industries TTM net income year-on-year change?
Over the past year, TARO TTM net profit has changed by +$21.11 M (+64.44%)